North America Degenerative Disc Disease Treatment Market Size, Share & Trends Analysis Report By Route of Administration, By Drugs, By End Use, By Treatment Type, By Country and Growth Forecast, 2024

List of Tables

The North America Degenerative Disc Disease Treatment Market would witness market growth of 4.8% CAGR during the forecast period (2024-2031).

The US market dominated the North America Degenerative Disc Disease Treatment Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $11,428.3 million by 2031. The Canada market is experiencing a CAGR of 7.1% during (2024 - 2031). Additionally, The Mexico market would exhibit a CAGR of 6.2% during (2024 - 2031).

Degenerative Disc Disease (DDD) treatment encompasses various strategies aimed at managing symptoms, reducing pain, and improving spinal function in individuals affected by disc degeneration. DDD primarily affects the intervertebral discs, which act as cushions between the vertebrae in the spine. Over time, these discs may deteriorate due to wear and tear and stiffness, resulting in pain and decreased mobility. The treatment aims to alleviate symptoms, prevent further degeneration, and restore or maintain spinal function.

In addition, DDD treatment encompasses a range of therapeutic approaches aimed at managing symptoms, preserving spinal function, and improving the quality of life for affected individuals. Physical therapy programs are customized to strengthen supportive muscles, enhance flexibility, and encourage correct spinal alignment. Therapeutic exercises and techniques such as traction may alleviate pain and prevent further degeneration. Non-steroidal anti-inflammatory drugs (NSAIDs), muscle relaxants, and pain relievers are frequently recommended for alleviating pain and inflammation related to DDD. These medications help reduce discomfort and improve mobility.

The Canadian healthcare sector's adoption of advanced medical technologies and minimally invasive surgical techniques enhances treatment outcomes for DDD patients. Innovations such as robotic-assisted surgeries and biologics contribute to improved patient recovery and satisfaction. Canada's emphasis on patient-centered care encourages the development of personalized treatment plans for individuals with degenerative disc disease. This approach integrates patient preferences and clinical outcomes, promoting the adoption of effective and tailored therapies. Also, Canada's aging population contributes to a higher prevalence of degenerative disc disease. This demographic shift creates a sustained demand for specialized treatments, including surgical and non-surgical interventions, driving growth in the degenerative disc disease treatment market. Thus, rising healthcare sector in North America will lead to increased demand for degenerative disc disease treatment in the region.

Based on Route of Administration, the market is segmented into Oral, and Injectable. Based on Drugs, the market is segmented into NSAIDs (Non-Steroidal Anti-Inflammatory Drugs), Acetaminophen, Muscle Relaxants, and Steroids. Based on End Use, the market is segmented into Hospitals, Clinics, and Others. Based on Treatment Type, the market is segmented into Physical Therapy, Occupational Therapy, Special Exercises, Weight Loss Surgery, and Medications. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

List of Key Companies Profiled

Medtronic PLC
AstraZeneca PLC
Pfizer, Inc.
Novartis AG
Eli Lilly And Company
Spine Wave Inc.
B. Braun Melsungen AG (Aesculap, Inc.)
DiscGenics, Inc.
Spine BioPharma Inc.
Stryker Corporation

North America Degenerative Disc Disease Treatment Market Report Segmentation

By Route of Administration

Oral
Injectable

By Drugs

NSAIDs (Non-Steroidal Anti-Inflammatory Drugs)
Acetaminophen
Muscle Relaxants
Steroids

By End Use

Hospitals
Clinics
Others

By Treatment Type

Physical Therapy
Occupational Therapy
Special Exercises
Weight Loss Surgery
Medications

By Country

US
Canada
Mexico
Rest of North America

Chapter 1. Market Scope & Methodology

1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
- 1.4.1 North America Degenerative Disc Disease Treatment Market, by Route of Administration
- 1.4.2 North America Degenerative Disc Disease Treatment Market, by Drugs
- 1.4.3 North America Degenerative Disc Disease Treatment Market, by End Use
- 1.4.4 North America Degenerative Disc Disease Treatment Market, by Treatment Type
- 1.4.5 North America Degenerative Disc Disease Treatment Market, by Country
1.5 Methodology for the research

Chapter 2. Market at a Glance

2.1 Key Highlights

Chapter 3. Market Overview

3.1 Introduction
- 3.1.1 Overview
  - 3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
- 3.2.1 Market Drivers
- 3.2.2 Market Restraints
- 3.2.3 Market Opportunities
- 3.2.4 Market Challenges
3.3 Porter Five Forces Analysis

Chapter 4. North America Degenerative Disc Disease Treatment Market by Route of Administration

4.1 North America Oral Market by Region
4.2 North America Injectable Market by Region

Chapter 5. North America Degenerative Disc Disease Treatment Market by Drugs

5.1 North America NSAIDs (Non-Steroidal Anti-Inflammatory Drugs) Market by Country
5.2 North America Acetaminophen Market by Country
5.3 North America Muscle Relaxants Market by Country
5.4 North America Steroids Market by Country

Chapter 6. North America Degenerative Disc Disease Treatment Market by End Use

6.1 North America Hospitals Market by Country
6.2 North America Clinics Market by Country
6.3 North America Others Market by Country

Chapter 7. North America Degenerative Disc Disease Treatment Market by Treatment Type

7.1 North America Physical Therapy Market by Country
7.2 North America Occupational Therapy Market by Country
7.3 North America Special Exercises Market by Country
7.4 North America Weight Loss Surgery Market by Country
7.5 North America Medications Market by Country

Chapter 8. North America Degenerative Disc Disease Treatment Market by Country

8.1 US Degenerative Disc Disease Treatment Market
- 8.1.1 US Degenerative Disc Disease Treatment Market by Route of Administration
- 8.1.2 US Degenerative Disc Disease Treatment Market by Drugs
- 8.1.3 US Degenerative Disc Disease Treatment Market by End Use
- 8.1.4 US Degenerative Disc Disease Treatment Market by Treatment Type
8.2 Canada Degenerative Disc Disease Treatment Market
- 8.2.1 Canada Degenerative Disc Disease Treatment Market by Route of Administration
- 8.2.2 Canada Degenerative Disc Disease Treatment Market by Drugs
- 8.2.3 Canada Degenerative Disc Disease Treatment Market by End Use
- 8.2.4 Canada Degenerative Disc Disease Treatment Market by Treatment Type
8.3 Mexico Degenerative Disc Disease Treatment Market
- 8.3.1 Mexico Degenerative Disc Disease Treatment Market by Route of Administration
- 8.3.2 Mexico Degenerative Disc Disease Treatment Market by Drugs
- 8.3.3 Mexico Degenerative Disc Disease Treatment Market by End Use
- 8.3.4 Mexico Degenerative Disc Disease Treatment Market by Treatment Type
8.4 Rest of North America Degenerative Disc Disease Treatment Market
- 8.4.1 Rest of North America Degenerative Disc Disease Treatment Market by Route of Administration
- 8.4.2 Rest of North America Degenerative Disc Disease Treatment Market by Drugs
- 8.4.3 Rest of North America Degenerative Disc Disease Treatment Market by End Use
- 8.4.4 Rest of North America Degenerative Disc Disease Treatment Market by Treatment Type

Chapter 9. Company Profiles

9.1 Medtronic PLC
- 9.1.1 Company overview
- 9.1.2 Financial Analysis
- 9.1.3 Segmental and Regional Analysis
- 9.1.4 Research & Development Expenses
- 9.1.5 Recent strategies and developments:
  - 9.1.5.1 Partnerships, Collaborations, and Agreements:
  - 9.1.5.2 Trail and Approvals:
- 9.1.6 SWOT Analysis
9.2 AstraZeneca PLC
- 9.2.1 Company Overview
- 9.2.2 Financial Analysis
- 9.2.3 Regional Analysis
- 9.2.4 Research & Development Expenses
- 9.2.5 SWOT Analysis
9.3 Pfizer, Inc.
- 9.3.1 Company Overview
- 9.3.2 Financial Analysis
- 9.3.3 Regional & Segmental Analysis
- 9.3.4 Research & Development Expense
- 9.3.5 SWOT Analysis
9.4 Novartis AG
- 9.4.1 Company Overview
- 9.4.2 Financial Analysis
- 9.4.3 Segmental and Regional Analysis
- 9.4.4 Research & Development Expense
- 9.4.5 Recent strategies and developments:
  - 9.4.5.1 Partnerships, Collaborations, and Agreements:
  - 9.4.5.2 Acquisition and Mergers:
- 9.4.6 SWOT Analysis
9.5 Eli Lilly And Company
- 9.5.1 Company Overview
- 9.5.2 Financial Analysis
- 9.5.3 Regional Analysis
- 9.5.4 Research & Development Expenses
- 9.5.5 SWOT Analysis
9.6 Spine Wave Inc.
- 9.6.1 Company Overview
9.7 B. Braun Melsungen AG (Aesculap, Inc.)
- 9.7.1 Company Overview
- 9.7.2 Financial Analysis
- 9.7.3 Segmental and Regional Analysis
- 9.7.4 Research & Development Expenses
- 9.7.5 SWOT Analysis
9.8 DiscGenics, Inc.
- 9.8.1 Company Overview
9.9 Spine BioPharma Inc.
- 9.9.1 Company Overview
9.10. Stryker Corporation
- 9.10.1 Company Overview
- 9.10.2 Financial Analysis
- 9.10.3 Segmental and Regional Analysis
- 9.10.4 Research & Development Expenses
- 9.10.5 SWOT Analysis

LIST OF TABLES

TABLE 1 North America Degenerative Disc Disease Treatment Market, 2020 - 2023, USD Million
TABLE 2 North America Degenerative Disc Disease Treatment Market, 2024 - 2031, USD Million
TABLE 3 North America Degenerative Disc Disease Treatment Market by Route of Administration, 2020 - 2023, USD Million
TABLE 4 North America Degenerative Disc Disease Treatment Market by Route of Administration, 2024 - 2031, USD Million
TABLE 5 North America Oral Market by Region, 2020 - 2023, USD Million
TABLE 6 North America Oral Market by Region, 2024 - 2031, USD Million
TABLE 7 North America Injectable Market by Region, 2020 - 2023, USD Million
TABLE 8 North America Injectable Market by Region, 2024 - 2031, USD Million
TABLE 9 North America Degenerative Disc Disease Treatment Market by Drugs, 2020 - 2023, USD Million
TABLE 10 North America Degenerative Disc Disease Treatment Market by Drugs, 2024 - 2031, USD Million
TABLE 11 North America NSAIDs (Non-Steroidal Anti-Inflammatory Drugs) Market by Country, 2020 - 2023, USD Million
TABLE 12 North America NSAIDs (Non-Steroidal Anti-Inflammatory Drugs) Market by Country, 2024 - 2031, USD Million
TABLE 13 North America Acetaminophen Market by Country, 2020 - 2023, USD Million
TABLE 14 North America Acetaminophen Market by Country, 2024 - 2031, USD Million
TABLE 15 North America Muscle Relaxants Market by Country, 2020 - 2023, USD Million
TABLE 16 North America Muscle Relaxants Market by Country, 2024 - 2031, USD Million
TABLE 17 North America Steroids Market by Country, 2020 - 2023, USD Million
TABLE 18 North America Steroids Market by Country, 2024 - 2031, USD Million
TABLE 19 North America Degenerative Disc Disease Treatment Market by End Use, 2020 - 2023, USD Million
TABLE 20 North America Degenerative Disc Disease Treatment Market by End Use, 2024 - 2031, USD Million
TABLE 21 North America Hospitals Market by Country, 2020 - 2023, USD Million
TABLE 22 North America Hospitals Market by Country, 2024 - 2031, USD Million
TABLE 23 North America Clinics Market by Country, 2020 - 2023, USD Million
TABLE 24 North America Clinics Market by Country, 2024 - 2031, USD Million
TABLE 25 North America Others Market by Country, 2020 - 2023, USD Million
TABLE 26 North America Others Market by Country, 2024 - 2031, USD Million
TABLE 27 North America Degenerative Disc Disease Treatment Market by Treatment Type, 2020 - 2023, USD Million
TABLE 28 North America Degenerative Disc Disease Treatment Market by Treatment Type, 2024 - 2031, USD Million
TABLE 29 North America Physical Therapy Market by Country, 2020 - 2023, USD Million
TABLE 30 North America Physical Therapy Market by Country, 2024 - 2031, USD Million
TABLE 31 North America Occupational Therapy Market by Country, 2020 - 2023, USD Million
TABLE 32 North America Occupational Therapy Market by Country, 2024 - 2031, USD Million
TABLE 33 North America Special Exercises Market by Country, 2020 - 2023, USD Million
TABLE 34 North America Special Exercises Market by Country, 2024 - 2031, USD Million
TABLE 35 North America Weight Loss Surgery Market by Country, 2020 - 2023, USD Million
TABLE 36 North America Weight Loss Surgery Market by Country, 2024 - 2031, USD Million
TABLE 37 North America Medications Market by Country, 2020 - 2023, USD Million
TABLE 38 North America Medications Market by Country, 2024 - 2031, USD Million
TABLE 39 North America Degenerative Disc Disease Treatment Market by Country, 2020 - 2023, USD Million
TABLE 40 North America Degenerative Disc Disease Treatment Market by Country, 2024 - 2031, USD Million
TABLE 41 US Degenerative Disc Disease Treatment Market, 2020 - 2023, USD Million
TABLE 42 US Degenerative Disc Disease Treatment Market, 2024 - 2031, USD Million
TABLE 43 US Degenerative Disc Disease Treatment Market by Route of Administration, 2020 - 2023, USD Million
TABLE 44 US Degenerative Disc Disease Treatment Market by Route of Administration, 2024 - 2031, USD Million
TABLE 45 US Degenerative Disc Disease Treatment Market by Drugs, 2020 - 2023, USD Million
TABLE 46 US Degenerative Disc Disease Treatment Market by Drugs, 2024 - 2031, USD Million
TABLE 47 US Degenerative Disc Disease Treatment Market by End Use, 2020 - 2023, USD Million
TABLE 48 US Degenerative Disc Disease Treatment Market by End Use, 2024 - 2031, USD Million
TABLE 49 US Degenerative Disc Disease Treatment Market by Treatment Type, 2020 - 2023, USD Million
TABLE 50 US Degenerative Disc Disease Treatment Market by Treatment Type, 2024 - 2031, USD Million
TABLE 51 Canada Degenerative Disc Disease Treatment Market, 2020 - 2023, USD Million
TABLE 52 Canada Degenerative Disc Disease Treatment Market, 2024 - 2031, USD Million
TABLE 53 Canada Degenerative Disc Disease Treatment Market by Route of Administration, 2020 - 2023, USD Million
TABLE 54 Canada Degenerative Disc Disease Treatment Market by Route of Administration, 2024 - 2031, USD Million
TABLE 55 Canada Degenerative Disc Disease Treatment Market by Drugs, 2020 - 2023, USD Million
TABLE 56 Canada Degenerative Disc Disease Treatment Market by Drugs, 2024 - 2031, USD Million
TABLE 57 Canada Degenerative Disc Disease Treatment Market by End Use, 2020 - 2023, USD Million
TABLE 58 Canada Degenerative Disc Disease Treatment Market by End Use, 2024 - 2031, USD Million
TABLE 59 Canada Degenerative Disc Disease Treatment Market by Treatment Type, 2020 - 2023, USD Million
TABLE 60 Canada Degenerative Disc Disease Treatment Market by Treatment Type, 2024 - 2031, USD Million
TABLE 61 Mexico Degenerative Disc Disease Treatment Market, 2020 - 2023, USD Million
TABLE 62 Mexico Degenerative Disc Disease Treatment Market, 2024 - 2031, USD Million
TABLE 63 Mexico Degenerative Disc Disease Treatment Market by Route of Administration, 2020 - 2023, USD Million
TABLE 64 Mexico Degenerative Disc Disease Treatment Market by Route of Administration, 2024 - 2031, USD Million
TABLE 65 Mexico Degenerative Disc Disease Treatment Market by Drugs, 2020 - 2023, USD Million
TABLE 66 Mexico Degenerative Disc Disease Treatment Market by Drugs, 2024 - 2031, USD Million
TABLE 67 Mexico Degenerative Disc Disease Treatment Market by End Use, 2020 - 2023, USD Million
TABLE 68 Mexico Degenerative Disc Disease Treatment Market by End Use, 2024 - 2031, USD Million
TABLE 69 Mexico Degenerative Disc Disease Treatment Market by Treatment Type, 2020 - 2023, USD Million
TABLE 70 Mexico Degenerative Disc Disease Treatment Market by Treatment Type, 2024 - 2031, USD Million
TABLE 71 Rest of North America Degenerative Disc Disease Treatment Market, 2020 - 2023, USD Million
TABLE 72 Rest of North America Degenerative Disc Disease Treatment Market, 2024 - 2031, USD Million
TABLE 73 Rest of North America Degenerative Disc Disease Treatment Market by Route of Administration, 2020 - 2023, USD Million
TABLE 74 Rest of North America Degenerative Disc Disease Treatment Market by Route of Administration, 2024 - 2031, USD Million
TABLE 75 Rest of North America Degenerative Disc Disease Treatment Market by Drugs, 2020 - 2023, USD Million
TABLE 76 Rest of North America Degenerative Disc Disease Treatment Market by Drugs, 2024 - 2031, USD Million
TABLE 77 Rest of North America Degenerative Disc Disease Treatment Market by End Use, 2020 - 2023, USD Million
TABLE 78 Rest of North America Degenerative Disc Disease Treatment Market by End Use, 2024 - 2031, USD Million
TABLE 79 Rest of North America Degenerative Disc Disease Treatment Market by Treatment Type, 2020 - 2023, USD Million
TABLE 80 Rest of North America Degenerative Disc Disease Treatment Market by Treatment Type, 2024 - 2031, USD Million
TABLE 81 Key Information - Medtronic PLC
TABLE 82 Key Information - AstraZeneca PLC
TABLE 83 Key Information - Pfizer, Inc.
TABLE 84 Key Information - Novartis AG
TABLE 85 Key Information - Eli Lilly And Company
TABLE 86 Key Information - Spine Wave Inc.
TABLE 87 Key Information - B. Braun Melsungen AG
TABLE 88 Key Information - DiscGenics, Inc.
TABLE 89 Key Information - Spine BioPharma Inc.
TABLE 90 Key Information - Stryker Corporation

North America Degenerative Disc Disease Treatment Market Size, Share & Trends Analysis Report By Route of Administration, By Drugs, By End Use, By Treatment Type, By Country and Growth Forecast, 2024 - 2031

Description

Table of Contents